» Articles » PMID: 30056429

Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2018 Jul 30
PMID 30056429
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There has been in recent decades a growing interest in the relationship between osteoporosis and cognitive decline.

Objective: The goal of this study was to analyze the impact of osteoporosis on the risk of dementia in patients followed for up to 20 years in general practices in Germany.

Methods: This study included patients who received an initial diagnosis of osteoporosis and were followed by 1,215 general practitioners in Germany between January 1993 and December 2012 (index date). Controls were matched (1:1) to osteoporosis patients using propensity scores based on age, gender, index year, comorbidities, and co-therapies. Kaplan-Meier curves were performed to study the development of dementia separately in men and women with or without osteoporosis within 20 years of the index date. Cox proportional regression models were used to estimate the relationship between osteoporosis and dementia in men and women.

Results: The present study included 29,983 cases and 29,983 controls. After 20 years of follow-up, 20.5% of women with osteoporosis and 16.4% of controls had been diagnosed with dementia (log-rank p-value <0.001). At the end of the follow-up period, dementia was found in 22.0% of men previously diagnosed with osteoporosis and 14.9% of men without this chronic condition (log-rank p-value <0.001). Osteoporosis was associated with a 1.2-fold increase in the risk of being diagnosed with dementia in women and a 1.3-fold increase in the risk of being diagnosed with dementia in men.

Conclusions: There was a positive association between osteoporosis and dementia in patients followed in general practices in Germany.

Citing Articles

Characterization of gene expression profiles in Alzheimer's disease and osteoarthritis: A bioinformatics study.

Liu N, Deng Q, Peng Z, Mao D, Huang Y, Meng F PLoS One. 2025; 20(2):e0316708.

PMID: 39919076 PMC: 11805404. DOI: 10.1371/journal.pone.0316708.


Association between Chronic Hepatitis B/C and Incidence of Osteoporosis and Bone Fractures: Results from a Retrospective Cohort Study.

Loosen S, Killer A, Bock H, Luedde T, Roderburg C, Kostev K J Clin Med. 2024; 13(20).

PMID: 39458102 PMC: 11508393. DOI: 10.3390/jcm13206152.


Identification of profiles associated with conversions between the Alzheimer's disease stages, using a machine learning approach.

Dauphinot V, Laurent M, Prodel M, Civet A, Vainchtock A, Moutet C Alzheimers Res Ther. 2024; 16(1):166.

PMID: 39061107 PMC: 11282744. DOI: 10.1186/s13195-024-01533-5.


The flavonoid fisetin reduces multiple physiological risk factors for dementia.

Maher P Neurochem Int. 2024; 178:105805.

PMID: 39004102 PMC: 11304624. DOI: 10.1016/j.neuint.2024.105805.


Crosstalk between bone and brain in Alzheimer's disease: Mechanisms, applications, and perspectives.

Liu Z, Liu M, Xiong Y, Wang Y, Bu X Alzheimers Dement. 2024; 20(8):5720-5739.

PMID: 38824621 PMC: 11350061. DOI: 10.1002/alz.13864.